Paradigm Diagnostics is a biotechnology startup that has been making waves in the healthcare industry since its founding in 2012. Its focus on advanced diagnostic technologies has attracted significant attention, particularly with its recent Series B investment of $15.00M in May 2019. The investment was led by a group of prominent investors, including Tech Coast Angels, Gore Range Capital, New Science Ventures, BlueStone Venture Partners, Mesa Verde Venture Partners, Prairie Ventures, and OSF Healthcare System.
General Information
BounceWatch is an independent company data service, not affiliated with Paradigm Diagnostics. To contact Paradigm Diagnostics, visit paradigmdx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Paradigm Diagnostics compare?
A PDF of Paradigm Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Paradigm Diagnostics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Biotechnology
About Paradigm Diagnostics
Funding Rounds & Investors (2)
View AllFAQ About Paradigm Diagnostics
We're actively collecting intelligence on Paradigm Diagnostics.
Source: BounceWatch company record for Paradigm Diagnostics, https://bouncewatch.com/company/paradigm-diagnostics, updated 12 September 2024. When citing, please name BounceWatch and link this page.